NCT04319159View on ClinicalTrials.gov

Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 5, 2020

Primary Completion Date

September 9, 2020

Study Completion Date

October 7, 2020

Conditions
Actinic Keratoses
Interventions
COMBINATION_PRODUCT

BF-200 ALA and red light LED lamp

Combination Product: Photodynamic therapy (PDT) using BF-RhodoLED® (ALA-PDT, Ameluz®-PDT).

Trial Locations (1)

78759

DermResearch Inc., Austin

Sponsors
All Listed Sponsors
lead

Biofrontera Bioscience GmbH

INDUSTRY

NCT04319159 - Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK) | Biotech Hunter | Biotech Hunter